Tersus Pharmaceuticals has positioned itself as the leading biopharmaceutical firm conducting research, development, and commercialisation of omega-7 fatty acids. Tersus Pharmaceuticals has patents granted and pending in a number of different areas, primarily surrounding the purification of omega-7 fatty acids and their therapeutic applications.
Tersus Pharmaceuticals has developed the science behind Provinal™, a patent pending ultrapurified form of omega-7 (palmitoleic acid). Palmitoleic acid is a monounsaturated fatty acid the next generation of omega fatty acids, and has been shown to possess broad therapeutic activity. In the areas of insulin resistance, obesity and cardiovascular health.
Provinal™ has been clinically studied and shown to optimise cholesterol levels and reduce inflammation, and is the subject of ongoing clinical trials in a number of therapeutic areas.